Japan AGM Voting Results & Director Approval
Annual meeting voting results, director support and shareholder dissent.
Data through · Updated with new filings
0
board nominees with under 80% support at 2026 meetings
The lowest was Astellas Pharma's nominee at 80.70%.
1 row matches “4503” · Clear · Go to Astellas Pharma (4503) →
Lowest director approval
11 meeting · 9 board nominees, each meeting's lowest approval first
The line marks 80% approval.
| Director | Proposal | Approval | Result | Filing |
|---|---|---|---|---|
| 高原 茂季+8 other nominees, 93.20%–98.60%Astellas Pharma4503 · アステラス製薬 | Election of 3 audit committee directorsOriginal (Japanese)監査等委員である取締役3名選任の件 | 80.70%Votes cast: 80.75% · For 11,201,089 / Against 2,668,032 / Abstain 2,026 | Approved | Filed — filing S100YOHK |
Rejected proposals
0No stored data for this selection.
Shareholder proposals ≥ 20%
0No stored data for this selection.
Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).
† Percentage of votes cast; company did not state a ratio.
† Company-stated ratio differs from tallied votes.
Related tools
Tender offers
Tender offer prices, windows, conditions and disclosed outcomes.
Activist & 5% stakes
Disclosed stakes above 5%, with activist groups and ownership changes.